Key Financial Data Of Reporting Company

SAPPORO CLINICAL LABORATORY INC. - Filing #7325055

Concept As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
17,333,697,000 JPY
19,682,319,000 JPY
17,613,669,000 JPY
20,127,692,000 JPY
17,737,144,000 JPY
19,109,595,000 JPY
16,372,822,000 JPY
17,502,544,000 JPY
16,507,881,000 JPY
17,659,084,000 JPY
Ordinary profit (loss)
598,333,000 JPY
514,777,000 JPY
895,308,000 JPY
1,159,449,000 JPY
1,567,931,000 JPY
1,605,618,000 JPY
1,170,964,000 JPY
1,188,144,000 JPY
944,056,000 JPY
982,982,000 JPY
Profit (loss)
460,452,000 JPY
471,722,000 JPY
1,024,167,000 JPY
791,119,000 JPY
503,372,000 JPY
Share capital
983,350,000 JPY
983,350,000 JPY
983,350,000 JPY
983,350,000 JPY
983,350,000 JPY
Total number of issued shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
4,216,000 xbrli:shares
Net assets
11,183,039,000 JPY
10,640,704,000 JPY
10,212,467,000 JPY
10,880,986,000 JPY
10,337,959,000 JPY
9,839,022,000 JPY
9,272,384,000 JPY
9,014,231,000 JPY
8,463,145,000 JPY
8,209,868,000 JPY
Total assets
16,680,947,000 JPY
15,057,391,000 JPY
14,487,068,000 JPY
16,521,281,000 JPY
16,149,449,000 JPY
14,440,322,000 JPY
14,511,471,000 JPY
13,662,749,000 JPY
11,553,144,000 JPY
10,708,787,000 JPY
Net assets per share
3,283.71
3,194.85
3,066.27
3,178.25
3,016.24
2,934.15
2,708.63
2,633.22
2,472.23
2,398.25
Dividend paid per share
23
23
23
23
10
Interim dividend paid per share
Basic earnings (loss) per share
138.25
114.14
141.47
170.53
300.67
306.16
231.10
231.85
147.04
154.30
Diluted earnings per share
Equity-to-asset ratio
0.656 xbrli:pure
0.707 xbrli:pure
0.705 xbrli:pure
0.641 xbrli:pure
0.626 xbrli:pure
0.681 xbrli:pure
0.639 xbrli:pure
0.660 xbrli:pure
0.733 xbrli:pure
0.767 xbrli:pure
Rate of return on equity
0.044 xbrli:pure
0.035 xbrli:pure
0.047 xbrli:pure
0.055 xbrli:pure
0.109 xbrli:pure
0.108 xbrli:pure
0.092 xbrli:pure
0.090 xbrli:pure
0.063 xbrli:pure
0.064 xbrli:pure
Price-earnings ratio
7.86 xbrli:pure
9.51 xbrli:pure
8.96 xbrli:pure
7.43 xbrli:pure
4.31 xbrli:pure
4.23 xbrli:pure
6.63 xbrli:pure
6.61 xbrli:pure
10.87 xbrli:pure
10.36 xbrli:pure
Payout ratio
0.166 xbrli:pure
0.163 xbrli:pure
0.076 xbrli:pure
0.100 xbrli:pure
0.068 xbrli:pure
Net cash provided by (used in) operating activities
1,077,593,000 JPY
1,430,350,000 JPY
1,573,628,000 JPY
837,590,000 JPY
1,255,547,000 JPY
Net cash provided by (used in) investing activities
-395,474,000 JPY
-409,028,000 JPY
-830,960,000 JPY
-3,148,264,000 JPY
-2,913,165,000 JPY
Net cash provided by (used in) financing activities
-369,961,000 JPY
-347,894,000 JPY
-112,738,000 JPY
1,943,634,000 JPY
-51,630,000 JPY
Cash and cash equivalents
3,966,205,000 JPY
3,654,048,000 JPY
2,980,620,000 JPY
2,350,691,000 JPY
2,717,730,000 JPY
Number of employees
324 xbrli:pure
287 xbrli:pure
21 xbrli:pure
287 xbrli:pure
539 xbrli:pure
21 xbrli:pure
3 xbrli:pure
21 xbrli:pure
871 xbrli:pure
3 xbrli:pure
635 xbrli:pure
627 xbrli:pure
938 xbrli:pure
871 xbrli:pure
622 xbrli:pure
819 xbrli:pure
775 xbrli:pure
820 xbrli:pure
779 xbrli:pure
Total shareholder return
0.603 xbrli:pure
0.683 xbrli:pure
0.686 xbrli:pure
0.794 xbrli:pure
0.816 xbrli:pure
Total return on share price index
1.962 xbrli:pure
1.388 xbrli:pure
1.312 xbrli:pure
1.286 xbrli:pure
0.905 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.